Article metrics

Download PDFPDF
00014 A PHASE II STUDY OF THE AGO OVARIAN CANCER STUDY GROUP (AGO-OVAR 2.6): ZD1839 IN COMBINATION WITH TAMOXIFEN IN REFRACTORY OVARIAN CANCER

 

Online download statistics by month:

Online download statistics by month: December 2019 to September 2024

AbstractFullPdf
Dec 2019002
Sep 2024001
Total003